Comparisons

• Epitalon vs DSIP (2026): Evidence & Legal Status Compared

  Epitalon vs DSIP: two research peptides both up for the July 2026 FDA vote on insomnia, with different biology and the same preclinical evidence.

• Epitalon vs MOTS-c (2026): Evidence & Legal Status Compared

  Epitalon vs MOTS-c: two research peptides marketed for longevity, with very different biology and the same July 2026 FDA compounding meeting.

• Epitalon vs Semax (2026): Evidence & Legal Status Compared

  Epitalon vs Semax: two research peptides from the same Russian lineage, stacked for anti-ageing and cognition, with the same July 2026 FDA review.

• Semax vs DSIP (2026): Evidence & Legal Status Compared

  Semax vs DSIP: two research neuropeptides with different targets — cognition versus sleep — and the same July 2026 FDA compounding vote.

• TB-500 vs KPV (2026): Evidence & Legal Status Compared

  TB-500 vs KPV: research peptides for wound healing and inflammation, both facing the same July 2026 FDA compounding vote, side by side.

• BPC-157 vs KPV (2026): Evidence & Legal Status Compared

  BPC-157 vs KPV: both are research peptides for healing and inflammation, facing the same July 2026 FDA compounding vote. Evidence and status, side by side.

• BPC-157 vs TB-500 (2026): Evidence & Legal Status Compared

  BPC-157 vs TB-500: research peptides for healing, both facing the same July 2026 FDA compounding vote. Evidence and regulations, side by side.